Our biosimilar manufacturing plant feasibility study and design delivers regulation-aligned, investment-optimized full-package solutions for the construction and upgrading of monoclonal antibody, protein drug and complex biosimilar production facilities. Tailored to the highly standardized, data-intensive and audit-driven characteristics of the biosimilar industry, our integrated service covers pre-project market and technical feasibility demonstration, investment risk evaluation, process layout planning and GMP-compliant plant overall design. Different from general pharmaceutical plant engineering, our scheme focuses on the core demands of biosimilar consistency evaluation, process reproducibility and strict global regulatory scrutiny, helping clients avoid technical barriers, compliance defects and over-investment risks in new plant construction or production line renovation. Suitable for greenfield plant development, old factory upgrading, and multi-product flexible biosimilar production base construction, our solution supports efficient project landing and long-term compliant commercial operation.
Core Design Philosophy
We adhere to the guiding principle of Data-Driven Feasibility, Process-Optimized Design, and Regulatory Resilient Construction, building high-standard biosimilar manufacturing plants that balance technical rationality, economic efficiency and global audit adaptability. All design logic closely fits the full production chain of biosimilar cell culture, protein purification, formulation preparation and sterile filling, solving industry pain points such as complex process validation, strict cross-contamination control and high facility standard thresholds.
Full-Dimension Feasibility Verification: Conduct in-depth demonstration covering market feasibility, technical feasibility, equipment matching, site adaptability, investment budget and profit forecast, providing scientific decision-making basis for project approval and investment.
Biosimilar Process-Oriented Layout: Centering on the unique production workflow of biological similar drugs, optimize cleanroom grading, personnel and material flow, process pipeline layout and functional zoning to ensure high process reproducibility.
Strict Cross-Contamination Prevention Mechanism: Adopt independent airflow organization, differential pressure control, dedicated logistics channels and closed production settings to meet the ultra-high isolation requirements of multi-biosimilar co-production.
Regulation-Upgraded Resilient Design: Reserve technical margins for iterative updates of global biosimilar guidelines, ensuring the plant design maintains long-term regulatory compliance and avoids repeated reconstruction caused by policy and standard upgrades.
Authoritative Regulatory Compliance System
Our feasibility study conclusions and plant design schemes fully comply with global mainstream biosimilar supervision standards and pharmaceutical engineering specifications, covering the whole chain of process validation, quality system construction, cleanroom environment control and data integrity. We deliver complete standardized technical documents and compliance proof materials to support clients’ project filing, drug registration, consistency evaluation and official GMP audit passing.
Global Biosimilar Regulatory Standards: In strict accordance with FDA, EMA and ICH guidelines for biosimilar development and manufacturing, realizing design docking with international high-end biosimilar production and registration requirements.
GMP & Pharmaceutical Engineering Norms: Fully compliant with cGMP, ISO 14644 cleanroom standards and ISPE pharmaceutical engineering specifications, realizing standardized construction of biological purification workshops and supporting facilities.
Full Data Integrity Compliance: Embedding 21 CFR Part 11 data management requirements in plant functional design, supporting whole-process production data traceability, electronic record validation and audit trail management.
Full-Lifecycle Integrated Services
We provide one-stop full-cycle services from preliminary project feasibility research, customized scheme design, refined engineering drawing output to later-stage construction guidance and compliance validation support, realizing seamless docking from project demonstration to formal compliant production.
Professional Project Feasibility Study: Deliver systematic feasibility reports including market analysis, technical route demonstration, risk assessment, investment estimation, benefit analysis and project implementation plan, supporting project approval and financing.
Overall Plant Planning & Functional Design: Complete scientific zoning of cell culture production area, purification preparation area, sterile filling area, reagent storage area, quality inspection laboratory and auxiliary engineering area to form an efficient and compliant production layout.
Specialized Biosimilar Process Engineering Design: Carry out targeted design for biological fermentation, cell culture, ultrafiltration purification, sterile preparation and other core processes, matching high-precision production and validation requirements of biosimilar products.
Compliance Documentation & Technical After-Service: Provide complete design documents, validation plans and compliance technical support, assist in construction supervision and project commissioning, and provide long-term technical services for product registration and factory compliance operation.
